期刊文献+

青春期多囊卵巢综合征筛查及干预研究进展 被引量:5

原文传递
导出
摘要 多囊卵巢综合征(polycysticovarysyndrome,PCOS)是育龄妇女常见的一种复杂的内分泌及代谢紊乱性疾病,是具有发病多因性、临床表现多态性的内分泌综合征。PCOS好发于青春期,多以月经稀发或继发性闭经等月经异常,及多毛、痤疮、
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2014年第3期231-233,共3页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 青春期 多囊卵巢综合征 筛查 干预 adolescence polycystic ovary syndrome screening intervention
  • 相关文献

参考文献10

二级参考文献136

  • 1倪仁敏,钟俊敏,陈晓莉,李琳,李予,陈亚肖,刘雯,杨冬梓.多囊卵巢综合征患者糖代谢异常发生率及其特点[J].中华糖尿病杂志,2009,1(6). 被引量:7
  • 2林金芳.青春期PCOS的临床与内分泌代谢特征及诊治[J].实用妇产科杂志,2005,21(9):528-530. 被引量:22
  • 3陈亚肖,杨冬梓,李琳,陈晓莉,李予.青春期和成年多囊卵巢综合征患者卵巢体积和卵泡数目的比较[J].中国临床医学影像杂志,2007,18(5):330-332. 被引量:10
  • 4杨冬梓,李琳,陈亚肖,等.青春期PCOS[j].妇产科学,2008,450.
  • 5Galluzzo A,Amato M C,Giordano C.Insulin resistance and polycystic ovary syndrome[J].Nutr Metab Cardiovasc Dis,2008,18 (7):511-518.
  • 6Blank S K,McCartney C R,Helm K D,et al.Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty[J].Semin Repord Med,2007,25(5):352-359.
  • 7Yoo R Y,Dewan A,Basu R,et al.Increased luteinizing hormone pulse frequency in obese oligomenorrheic girls with no evidence of hyperandrogenism[J].Fertil Steril,2006,85(4):1049-1056.
  • 8Awdishu S,Williams N I,Laredo S E,et al.Oligomenorrhoea in exercising women:a polycystic ovarian syndrome phenotype or distinct entity[J]?Sports Med,2009,39(12):1055-1069.
  • 9Robeva R,Mekhandzhiev Ts,Tomova A,et al.The anti-mullerian hormone-physiology and application into clinical practice[J].Akush Ginekol,2006,45(7):50-54.
  • 10Stubbs S A,Hardy K,DaSilva B P,et al.Anti-mullerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries[J].Clin Endocrinol Metab,2005,90(10):5536-5543.

共引文献91

同被引文献35

  • 1乐杰.妇产科学[M].7版.北京:人民卫生出版社,2010:366.
  • 2吴在德,吴肇汉.外科学[M].7版.北京:人民卫生出版社,2011:169-171.
  • 3American Diabetes Association.Consensus development conference on insulin resistance[J].Diabetes Care, 1998,21 (2):310.
  • 4Teede H,Deeks A,Moran L.Polycystic ovary syndrome "a complex condition with psychplogical,reproductive and metabolic manifes- tations that impacts on health across the lifespan[J].BMC Med,2010, 30(8):41.
  • 5De Leo V, Musacchio MC,Morgante G,et al.Metformin treatment is effective in obese teenage girls with PCOS[J].Hum Reprod,2006, 21(9):2252-2256.
  • 6Bridger T, MacDonald S,Baltzer F, et al.Randomized placebo- controlled trial of metformin for adolescents with polycystic ovary syndrome[J].Arch Pediatr Adolesc Med,2006,160(3):241-246.
  • 7Sahin I,Serter R, Karakut F, et al.Metformin versus flutamde in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome:a randomized prospective study [J].Gyne Col Endocrinol,2004,19(3): 115-124.
  • 8Lehmann JM,Moore LB,Smith-Oliver TA,et al.An antidiabetic thiazoli dinedione is a high affinity ligand for peroxisome proli- ferator activated receptor[J].J Biol Chem,1998,270(22):12953- 12956.
  • 9Ortega-Gonzalez C,Luna S,Hernandez L,et al.Responses of serum androgen and insulin resistance to methormin and pioglitazone in obese,insulin resistant women with polyeystie ovarysyndrome[J].J Clin Endocrinol Metab,2005,90(3): 1360-1365.
  • 10Glueck CJ,Moreira A,Goldenberg N,et al.pioglitazone and rnetfo- rmin in obese women with polycystic ovary syndrome not optimally responsive to metformin[J].Hum Reprod,2008,18(8): 1618-1625.

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部